Skip to main content
SpringerLink
Log in

O-RADS MRI: where are we and where we are going?

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. O-Rads. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/O-Rads. Accessed 7 Nov 2020

  2. Thomassin-Naggara I, Aubert E, Rockall A et al (2013) Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 267:432–443. https://doi.org/10.1148/radiol.13121161

    Article  PubMed  Google Scholar 

  3. Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A et al (2020) Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open 3:e1919896. https://doi.org/10.1001/jamanetworkopen.2019.19896

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rizzo S, Cozzi A, Dolciami M et al (2023) O-RADS MRI: a systematic review and meta-analysis of diagnostic performance and category-wise malignancy rates. Radiology 307:e220795. https://doi.org/10.1148/radiol.220795

    Article  PubMed  Google Scholar 

  5. Zhang Q, Dai X, Li W (2023) Systematic review and meta-analysis of O-RADS ultrasound and O-RADS MRI for risk assessment of ovarian and adnexal lesions. AJR Am J Roentgenol. https://doi.org/10.2214/AJR.22.28396

    Article  PubMed  Google Scholar 

  6. Thomassin-Naggara I, Belghitti M, Milon A et al (2021) O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort. Eur Radiol. https://doi.org/10.1007/s00330-021-08054-x

    Article  PubMed  PubMed Central  Google Scholar 

  7. Forstner R, Thomassin-Naggara I, Cunha TM et al (2017) ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol 27:2248–2257. https://doi.org/10.1007/s00330-016-4600-3

    Article  PubMed  Google Scholar 

  8. Thomassin-Naggara I, Daraï E, Nassar-Slaba J et al (2007) Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. J Comput Assist Tomogr 31:236–242. https://doi.org/10.1097/01.rct.0000237810.88251.9e

    Article  PubMed  Google Scholar 

  9. ClinicalTrials.gov. ADNEXMR scoring system: impact of an MR scoring system of therapeutic strategy of pelvic adnexal masses (ASCORDIA). https://clinicaltrials.gov/ct2/show/NCT02664597?term=NCT02664597&draw=2&rank=1. Accessed 06 Mar 2013

  10. SRCTN Registry. MR in ovarian cancer. http://www.isrctn.com/ISRCTN51246892. Accessed 17 Nov 2015

  11. Assouline V, Dabi Y, Jalaguier-Coudray A et al (2022) How to improve O-RADS MRI score for rating adnexal masses with cystic component? Eur Radiol 32:5943–5953. https://doi.org/10.1007/s00330-022-08644-3

    Article  CAS  PubMed  Google Scholar 

  12. Hottat NA, Van Pachterbeke C, Vanden-Houte K et al (2020) Magnetic resonance scoring system for the assessment of ovarian and adnexal masses: added value of diffusion-weighted imaging including the apparent diffusion coefficient map. Ultrasound Obstet Gynecol. https://doi.org/10.1002/uog.22090

    Article  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. Service d’Imageries Radiologiques et Interventionnelles Spécialisées, APHP – Hôpital Tenon, Paris, France

    Isabelle Thomassin-Naggara & Leo Razakamanantsoa

  2. Inserm NSERM U938, Sorbonne Université, Paris, France

    Isabelle Thomassin-Naggara & Leo Razakamanantsoa

  3. Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, England

    Andrea Rockall

Authors
  1. Isabelle Thomassin-Naggara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leo Razakamanantsoa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Rockall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabelle Thomassin-Naggara.

Ethics declarations

Guarantor

The scientific guarantor of this publication is I. Thomassin-Naggara.

Conflict of interest

The authors of this manuscript declare relationships with the following companies:

I. Thomassin-Naggara (General Electric, Siemens, Canon, Bard, Hologic, Guerbet, Fujifilm, Bracco, Bayer, iCAD, Incepto, GSK) for remunerated lectures or board outside the subject of the paper.

Andrea Rockall (advisory board member of RoCLub) outside the subject of the paper. Andrea Rockall is supported by the NIHR Imperial Biomedical Research Centre (BRC).

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

N/A

Ethical approval

N/A

Study subjects or cohorts overlap

N/A

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thomassin-Naggara, I., Razakamanantsoa, L. & Rockall, A. O-RADS MRI: where are we and where we are going?. Eur Radiol 33, 8155–8156 (2023). https://doi.org/10.1007/s00330-023-09732-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09732-8

Search

Navigation